IWM
TEVA icon

IHT Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

IHT Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Sell
6,115
-1,410
-19% -$47K ﹤0.01% 1173
2026
Q1 		$227K Buy
7,525
+486
+7% +$15.6K 0.01% 1133
2025
Q4 		$220K Buy
+7,039
New +$173K 0.01% 1094
2020
Q4 		– Sell
-11,227
Closed -$101K – 769
2020
Q3 		$101K Buy
+11,227
New +$119K 0.01% 632
2018
Q2 		– Sell
-3,187
Closed -$53K – 1260
2018
Q1 		$53K Sell
3,187
-113
-3% -$2.21K 0.01% 656
2017
Q4 		$63K Buy
3,300
+27
+0.8% +$406 0.02% 625
2017
Q3 		$52K Buy
3,273
+148
+5% +$3.33K 0.02% 514
2017
Q2 		$12K Buy
3,125
+1,352
+76% +$41.8K 0.01% 927
2017
Q1 		$57K Buy
1,773
+109
+7% +$3.72K 0.04% 389
2016
Q4 		$62K Buy
+1,664
New +$66.4K 0.05% 344

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

IHT Wealth Management's TEVA Position: Q2 2026 in Review

IHT Wealth Management reduced its Teva Pharmaceuticals (TEVA) stake by 19% in Q2 2026, selling an estimated $47K and leaving 6,115 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #1173.

IHT Wealth Management first reported a position in TEVA in Q4 2016 and has held it in 10 quarters since. The position peaked at $227K in Q1 2026. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • IHT Wealth Management held 6,115 shares of Teva Pharmaceuticals worth $207K as of Q2 2026.
  • IHT Wealth Management sold 1,410 Teva Pharmaceuticals shares in Q2 2026, an estimated $47K.
  • Teva Pharmaceuticals made up ﹤0.01% of IHT Wealth Management's portfolio in Q2 2026, its #1173 holding.
  • IHT Wealth Management first reported a position in Teva Pharmaceuticals in Q4 2016 and has held it in 10 quarters since.
  • IHT Wealth Management's Teva Pharmaceuticals position peaked at $227K in Q1 2026.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on IHT Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.